www.quralis.com/HealthcareFounded: 2016
QurAlis is a clinical-stage biotechnology company that is developing precision medicines with genetically validated targets for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. Its proprietary platforms and biomarkers aim to allow for the design and development of drugs that target disease-causing genetic alterations directly.
